Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Author index

Page Path
HOME > Browse > Author index
Search
Masato Iwabu  (Iwabu M) 1 Article
Obesity and Metabolic Syndrome
Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity
Miki Okada-Iwabu, Masato Iwabu, Kohjiro Ueki, Toshimasa Yamauchi, Takashi Kadowaki
Diabetes Metab J. 2015;39(5):363-372.   Published online October 22, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.5.363
  • 6,675 View
  • 60 Download
  • 39 Web of Science
  • 42 Crossref
AbstractAbstract PDFPubReader   

Obesity associated with unhealthy diet and lack of exercise is shown to contribute to the onset and/or aggravation of the metabolic syndrome and diabetes, thus placing affected individuals at increased risk of cardiovascular disease and cancer. Plasma adiponectin levels are decreased in obesity, which causes insulin resistance and diabetes. Therefore, we identified adiponectin receptors (AdipoRs) as the therapeutic target. It was suggested that, similarly to caloric restriction and exercise, activation of the AdipoRs may have the potential not only to improve lifestyle-related diseases but to contribute to prolonged the shortened lifespan on a high caloric unhealthy diet. To this end, we have identified "AdipoRon" as an adiponectin receptor agonist. Indeed, AdipoRon ameliorated diabetes associated with obesity as well as to increase exercise endurance, thus prolonging shortened lifespan of obese mice fed on a high fat diet. Additionally, we have recently determined the crystal structures of the human AdipoRs. The seven-transmembrane helices of AdipoRs are structurally distinct from those of G-protein coupled receptors. It is expected that these findings will contribute not only to the elucidation of the AdipoR-related signal transduction but to the development and optimization of AdipoR-targeted therapeutics for obesity-related diseases such as diabetes.

Citations

Citations to this article as recorded by  
  • Identification of a novel adiponectin receptor and opioid receptor dual acting agonist as a potential treatment for diabetic neuropathy
    Oscar Ka-Fai Ma, Simone Ronsisvalle, Livia Basile, Ariya Weiman Xiang, Cristina Tomasella, Federica Sipala, Matteo Pappalardo, Koon-Ho Chan, Danilo Milardi, Roy Chun-Laam Ng, Salvatore Guccione
    Biomedicine & Pharmacotherapy.2023; 158: 114141.     CrossRef
  • AdipoRon Effect on Expression of Lipid Metabolism Genes in Cultured Human Primary Macrophages
    I. A. Pobozheva, K. V. Dracheva, S. N. Pchelina, V. V. Miroshnikova
    Molecular Biology.2023; 57(4): 616.     CrossRef
  • The Antiviral Potential of AdipoRon, an Adiponectin Receptor Agonist, Reveals the Ability of Zika Virus to Deregulate Adiponectin Receptor Expression
    Daed El Safadi, Grégorie Lebeau, Jonathan Turpin, Christian Lefebvre d’Hellencourt, Nicolas Diotel, Wildriss Viranaicken, Pascale Krejbich-Trotot
    Viruses.2023; 16(1): 24.     CrossRef
  • The effects of high intensity-interval training on vaspin, adiponectin and leptin levels in women with polycystic ovary syndrome
    H. Ş. Aktaş, Y. E. Uzun, O. Kutlu, H. H. Pençe, F. Özçelik, E. Ö. Çil, L. Irak, Ö. Altun, M. Özcan, N. Özsoy, Ş. Aydın Yoldemir, S. Kalyon, Y. Arman, T. Tükek
    Archives of Physiology and Biochemistry.2022; 128(1): 37.     CrossRef
  • G protein-coupled receptors that influence lifespan of human and animal models
    Francisco Alejandro Lagunas-Rangel
    Biogerontology.2022; 23(1): 1.     CrossRef
  • Protective effects of AdipoRon on the liver of Huoyan goose fed a high-fat diet
    Zhongzan Cao, Ben Ma, Chengyu Cui, Jiahui Zhao, Sidi Liu, Yunqiao Qiu, Yan Zheng, Ming Gao, Xinhong Luan
    Poultry Science.2022; 101(4): 101708.     CrossRef
  • AdipoRon exerts opposing effects on insulin sensitivity via fibroblast growth factor 21–mediated time-dependent mechanisms
    Yongliang Wang, Huan Liu, Ruixin Zhang, Yuyao Xiang, Junfeng Lu, Bo Xia, Liang Peng, Jiangwei Wu
    Journal of Biological Chemistry.2022; 298(3): 101641.     CrossRef
  • Compendious Review on Adipokines of Corpulence
    Feryal Hashim
    Research Journal of Pharmacy and Technology.2022; : 4315.     CrossRef
  • AdipoR agonist increases insulin sensitivity and exercise endurance in AdipoR-humanized mice
    Masato Iwabu, Miki Okada-Iwabu, Hiroaki Tanabe, Nozomi Ohuchi, Keiko Miyata, Toshiko Kobori, Sara Odawara, Yuri Kadowaki, Shigeyuki Yokoyama, Toshimasa Yamauchi, Takashi Kadowaki
    Communications Biology.2021;[Epub]     CrossRef
  • ADIPOR1 regulates genes involved in milk fat metabolism in goat mammary epithelial cells
    Wangsheng Zhao, Michael Adjei, Hongmei Wang, Yueling Yangliu, Jiangjiang Zhu, Huijuan Wu
    Research in Veterinary Science.2021; 137: 194.     CrossRef
  • Differentiation of THP-1 monocytes to macrophages increased mitochondrial DNA copy number but did not increase expression of mitochondrial respiratory proteins or mitochondrial transcription factor A
    Mizuho Okamoto, Masanori Shimogishi, Akari Nakamura, Yusuke Suga, Kyosuke Sugawara, Michio Sato, Ryotaro Nishi, Akio Fujisawa, Yorihiro Yamamoto, Misato Kashiba
    Archives of Biochemistry and Biophysics.2021; 710: 108988.     CrossRef
  • Clinical features, treatment and rehabilitation of new coronavirus infection in patients with metabolic syndrome
    Dmitry O. Ivanov, Yury P. Uspenskiy, Andrey M. Sarana, Yulia A. Fominykh, Iana V. Sousova, Dmitry V. Zakharov
    Pediatrician (St. Petersburg).2021; 12(5): 5.     CrossRef
  • AdipoRon promotes diabetic fracture repair through endochondral ossification-based bone repair by enhancing survival and differentiation of chondrocytes
    Zhongyi Wang, Jinxin Tang, Ying Li, Yu Wang, Yanyang Guo, Qisheng Tu, Jake Chen, Chen Wang
    Experimental Cell Research.2020; 387(2): 111757.     CrossRef
  • Discovery of AdipoRon analogues as novel AMPK activators without inhibiting mitochondrial complex I
    Geng Sun, Yanping You, Haobin Li, Yalong Cheng, Ming Qian, Xinyu Zhou, Haoliang Yuan, Qing-Long Xu, Liang Dai, Pengfei Wang, Keguang Cheng, Xiaoan Wen, Caiping Chen
    European Journal of Medicinal Chemistry.2020; 200: 112466.     CrossRef
  • Insights Into the Controversial Aspects of Adiponectin in Cardiometabolic Disorders
    Emilio Antonio Francischetti, Rômulo Sperduto Dezonne, Cláudia Maria Pereira, Cyro José de Moraes Martins, Bruno Miguel Jorge Celoria, Patrícia Aguiar Cardoso de Oliveira, Virgínia Genelhu de Abreu
    Hormone and Metabolic Research.2020; 52(10): 695.     CrossRef
  • Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?
    Michel Abou-Samra, Camille M. Selvais, Nicolas Dubuisson, Sonia M. Brichard
    International Journal of Molecular Sciences.2020; 21(7): 2620.     CrossRef
  • AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy
    Michel Abou‐Samra, Camille M. Selvais, Raphael Boursereau, Sophie Lecompte, Laurence Noel, Sonia M. Brichard
    Journal of Cachexia, Sarcopenia and Muscle.2020; 11(2): 518.     CrossRef
  • Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease
    Rim Rafeh, Anissa Viveiros, Gavin Y. Oudit, Ahmed F. El-Yazbi
    Clinical Science.2020; 134(7): 827.     CrossRef
  • Therapeutic effects of AdipoRon on liver inflammation and fibrosis induced by CCl4 in mice
    Min Sha, Yaru Gao, Can Deng, Yuemeng Wan, Yuan Zhuang, Xiaochuan Hu, Ying Wang
    International Immunopharmacology.2020; 79: 106157.     CrossRef
  • AdipoRon: A Novel Insulin Sensitizer in Various Complications and the Underlying Mechanisms: A Review
    Ishfaq Ahmad Bhat, Shaheen Wasil Kabeer, Mohammad Irshad Reza, Reyaz Hassan Mir, Muhammad Ovais Dar
    Current Molecular Pharmacology.2020; 13(2): 94.     CrossRef
  • Case Report: Concurrent Resistance and Aerobic Training Regulate Adiponectin Expression and Disease Severity in Multiple Sclerosis: A Case Study
    Elisa Grazioli, Ersilia Nigro, Claudia Cerulli, Giovanna Borriello, Annamaria Mancini, Eliana Tranchita, Rita Polito, Attilio Parisi, Pasqualina Buono, Aurora Daniele
    Frontiers in Neuroscience.2020;[Epub]     CrossRef
  • Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease
    Yaeni Kim, Cheol Whee Park
    International Journal of Molecular Sciences.2019; 20(7): 1782.     CrossRef
  • Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity
    Miki Okada-Iwabu, Masato Iwabu, Toshimasa Yamauchi, Takashi Kadowaki
    Diabetology International.2019; 10(4): 237.     CrossRef
  • Potential Role of Adiponectin Receptor Agonist, AdipoRon in Cardiometabolic Disease
    Eunhee Cho, Sewon Lee
    Exercise Science.2019; 28(2): 102.     CrossRef
  • Adiponectin for the treatment of diabetic nephropathy
    Jun Young Lee, Jae Won Yang, Byoung Geun Han, Seung Ok Choi, Jae Seok Kim
    The Korean Journal of Internal Medicine.2019; 34(3): 480.     CrossRef
  • Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice
    Wen-Ze Xiao, Li Zhang
    Chinese Medical Journal.2019; 132(20): 2438.     CrossRef
  • Adiponectin/AdipoR Research and Its Implications for Lifestyle-Related Diseases
    Masato Iwabu, Miki Okada-Iwabu, Toshimasa Yamauchi, Takashi Kadowaki
    Frontiers in Cardiovascular Medicine.2019;[Epub]     CrossRef
  • Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases
    Ying Liu, Vivian Vu, Gary Sweeney
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • The role of immune cells in the development of adipose tissue dysfunction in cardiovascular diseases
    E. G. Uchasova, O. V. Gruzdeva, Yu. A. Dyleva, E. V. Belik, O. L. Barbarash
    Russian Journal of Cardiology.2019; (4): 92.     CrossRef
  • Adiponectin and Inflammation in Health and Disease: An Update
    Alice G. Geagea, Samir Mallat, Charbel F. Matar, Raymond Zerbe, Estelle Filfili, Maria Francis, Hanine Haidar, Abdo Jurjus
    Open Medicine Journal.2018; 5(1): 20.     CrossRef
  • Structure and function analysis of adiponectin receptors toward development of novel antidiabetic agents promoting healthy longevity
    Miki Okada-Iwabu, Masato Iwabu, Toshimasa Yamauchi, Takashi Kadowaki
    Endocrine Journal.2018; 65(10): 971.     CrossRef
  • Adiponectin induced AMP-activated protein kinase impairment mediates insulin resistance in Bama mini-pig fed high-fat and high-sucrose diet
    Miaomiao Niu, Lei Xiang, Yaqian Liu, Yuqiong Zhao, Jifang Yuan, Xin Dai, Hua Chen
    Asian-Australasian Journal of Animal Sciences.2017; 30(8): 1190.     CrossRef
  • The role of adiponectin receptors in the regulation of synaptic transmission in the hippocampus
    Filippo Weisz, Sonia Piccinin, Dalila Mango, Richard Teke Ngomba, Nicola B. Mercuri, Ferdinando Nicoletti, Robert Nisticò
    Synapse.2017;[Epub]     CrossRef
  • Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease
    Lavinia Woodward, Ioannis Akoumianakis, Charalambos Antoniades
    British Journal of Pharmacology.2017; 174(22): 4007.     CrossRef
  • Annual banned‐substance review: analytical approaches in human sports drug testing
    Mario Thevis, Tiia Kuuranne, Hans Geyer, Wilhelm Schänzer
    Drug Testing and Analysis.2017; 9(1): 6.     CrossRef
  • Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets
    Yadan Chen, Haiming Ma, Dasheng Zhu, Guowei Zhao, Lili Wang, Xiujuan Fu, Wei Chen
    PPAR Research.2017; 2017: 1.     CrossRef
  • Adiponectin and Its Receptors in Diabetic Kidney Disease: Molecular Mechanisms and Clinical Potential
    Dongqing Zha, Xiaoyan Wu, Ping Gao
    Endocrinology.2017; 158(7): 2022.     CrossRef
  • Role of pro- and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity
    Luciano Pirola, José Candido Ferraz
    World Journal of Biological Chemistry.2017; 8(2): 120.     CrossRef
  • Perivascular adipose tissue as a regulator of vascular disease pathogenesis: identifying novel therapeutic targets
    Ioannis Akoumianakis, Akansha Tarun, Charalambos Antoniades
    British Journal of Pharmacology.2017; 174(20): 3411.     CrossRef
  • Insight into the Dissociation of Behavior from Histology in Synucleinopathies and in Related Neurodegenerative Diseases
    Kazunari Sekiyama, Yoshiki Takamatsu, Wakako Koike, Masaaki Waragai, Takato Takenouchi, Shuei Sugama, Makoto Hashimoto
    Journal of Alzheimer's Disease.2016; 52(3): 831.     CrossRef
  • Castration induced browning in subcutaneous white adipose tissue in male mice
    Osamu Hashimoto, Tatsuya Noda, Atsushi Morita, Masahiro Morita, Hirofumi Ohtsuki, Makoto Sugiyama, Masayuki Funaba
    Biochemical and Biophysical Research Communications.2016; 478(4): 1746.     CrossRef
  • Aldosterone Production and Signaling Dysregulation in Obesity
    Andrea Vecchiola, Carlos F. Lagos, Cristian A. Carvajal, Rene Baudrand, Carlos E. Fardella
    Current Hypertension Reports.2016;[Epub]     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal